Kristle Spicuzza, in Chalmette, LA - Occupational Therapist

Kristle Spicuzza, is a Occupational Therapist based in Chalmette, Louisiana. Kristle Spicuzza is licensed to practice in Louisiana (license number OTT.200402) and her current practice location is 3209 Plaza Dr, Chalmette, Louisiana. She can be reached at her office (for appointments etc.) via phone at (150) 466-6060.

NPI number for Kristle Spicuzza is 1649046418 and her current mailing address is 200 E Saint Bernard Hwy, Chalmette, Louisiana. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1649046418.

Contact Information

	Kristle Spicuzza,
	3209 Plaza Dr, Chalmette, LA 70043-3541
	(150) 466-6060
	Not Available

Healthcare Provider's Profile

Full Name	Kristle Spicuzza
Gender	Female
Speciality	Occupational Therapist
Location	3209 Plaza Dr, Chalmette, Louisiana
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1649046418
Provider Enumeration Date: 12/01/2023
Last Update Date: 12/01/2023

Medical Identifiers

Medical identifiers for Kristle Spicuzza such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1649046418	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
225X00000X	Occupational Therapist	OTT.200402 (Louisiana)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Kristle Spicuzza is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Kristle Spicuzza, 200 E Saint Bernard Hwy, Chalmette, LA 70043-5162 Ph: (504) 301-2000	Kristle Spicuzza, 3209 Plaza Dr, Chalmette, LA 70043-3541 Ph: (150) 466-6060

News Archive

Harnessing proteomics could improve therapeutic approaches to COVID-19

A research group in India has recently described how the field of proteomics could be pivotal in helping to tackle the current coronavirus disease 2019 (COVID-19) pandemic.

How toxic are chloroquine and hydroxychloroquine to cells?

The spread of the pandemic disease COVID-19 caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has now reached almost every country of the world, with over 3.11 million cases and over 217,000 deaths as of April 29, 2020.

Novel androgens play major role in development of PCOS, research shows

Scientists led by the University of Birmingham have discovered that a new class of male sex hormones known as androgens plays a key role in the development of polycystic ovary syndrome (PCOS).

Research suggests blocking HMGB1 protein can benefit cancer patients

Like some people, cells eat when they are under pressure-but they consume parts of themselves. A multi-function protein helps control this form of cannibalism, according to a study in the September 6 issue of the Journal of Cell Biology.

Kristle Spicuzza, - Occupational Therapist in Chalmette, LA